The recent study by Ndembi and colleagues on the epidemiology of mpox in Africa1 provided a thorough analysis of the disease's spread across the continent. However, we would like to highlight an ...

Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey.

The WHO's interim guidance on social and behavioral research for the mpox response emphasizes the integration of ethical, ...

The world has already witnessed the cost of underestimating an infectious disease. Pakistan has a chance to act before mpox becomes a crisis. A contingency plan must be devised from the get go.

Sierra Leone on Wednesday started injecting frontline health care workers and high-risk individuals and children from age 12 ...

A new mutated variant of Mpox has been identified in Democratic Republic of Congo, with health authorities concerned over increased transmissibility. The new variant comes from the clade 1a strain ...

The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.

The study addresses a critical question in public health: could mpox evolve to become efficiently airborne like its viral relative, smallpox? While close physical contact remains the dominant mode ...

The MVA-BN vaccine showed an overall effectiveness of 57.8% (95% CI, 11.8-83.0) in reducing mpox cases at 14 days or longer after the first dose; however, the effectiveness was lower in people ...

WHO had declared an emergency for mpox in 2022. Such declarations pave the way for international efforts to curb the spread of the virus. Universiti Putra Malaysia consultant clinical ...